会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • HYDROXYLATED CONTRAST ENHANCEMENT AGENTS AND IMAGING METHOD
    • 羟基对比增强剂和成像方法
    • US20110243858A1
    • 2011-10-06
    • US13077746
    • 2011-03-31
    • Brian James GrimmondMichael James RishelRong ZhangJeannette Christine Roberts
    • Brian James GrimmondMichael James RishelRong ZhangJeannette Christine Roberts
    • A61K49/10A61K49/00A61P43/00
    • A61K49/103
    • A method of diagnostic imaging is disclosed comprising administering a medical formulation to a subject, the formulation comprising a contrast enhancement agent having structure I and salts thereof wherein R1 is independently at each occurrence a hydroxy group, a C1-C3 hydroxyalkyl group, or a C1-C3 alkyl group, and b is 0-4; R2-R7 are independently at each occurrence hydrogen, a C1-C3 hydroxyalkyl group, or a C1-C3 alkyl group, with the proviso that at least one of R1-R7 is a hydroxy group or a C1-C3 hydroxyalkyl group; and wherein Q is one or more charge balancing counterions; and one or more pharmaceutically acceptable carriers and excipients. The subject is subjected to a diagnostic imaging technique such as magnetic resonance imaging. The technique may be used in a variety of diagnostic imaging regimes, such as imaging of circulatory systems, genitourinary systems, hepatobiliary systems, central nervous systems, tumors, and abscesses among others.
    • 公开了一种诊断成像方法,其包括向受试者施用药物制剂,所述制剂包含具有结构I的对比增强剂及其盐,其中R1在每次出现时独立地为羟基,C1-C3羟烷基或C1 -C 3烷基,b为0-4; R2-R7各自独立地为氢,C1-C3羟基烷基或C1-C3烷基,条件是R1-R7中的至少一个为羟基或C1-C3羟烷基; 并且其中Q是一个或多个电荷平衡抗衡离子; 和一种或多种药学上可接受的载体和赋形剂。 对受试者进行诸如磁共振成像的诊断成像技术。 该技术可用于各种诊断成像方案,例如循环系统的成像,泌尿生殖系统,肝胆系统,中枢神经系统,肿瘤和脓肿等。
    • 5. 发明授权
    • Hydroxylated contrast enhancement agents and imaging method
    • 羟基化对比增强剂和成像方法
    • US08765977B2
    • 2014-07-01
    • US13077746
    • 2011-03-31
    • Brian James GrimmondMichael James RishelRong ZhangJeannette Christine Roberts
    • Brian James GrimmondMichael James RishelRong ZhangJeannette Christine Roberts
    • C07D319/08C07D309/30
    • A61K49/103
    • A method of diagnostic imaging is disclosed comprising administering a medical formulation to a subject, the formulation comprising a contrast enhancement agent having structure I and salts thereof wherein R1 is independently at each occurrence a hydroxy group, a C1-C3 hydroxyalkyl group, or a C1-C3 alkyl group, and b is 0-4; R2-R7 are independently at each occurrence hydrogen, a C1-C3 hydroxyalkyl group, or a C1-C3 alkyl group, with the proviso that at least one of R1-R7 is a hydroxy group or a C1-C3 hydroxyalkyl group; and wherein Q is one or more charge balancing counterions; and one or more pharmaceutically acceptable carriers and excipients. The subject is subjected to a diagnostic imaging technique such as magnetic resonance imaging. The technique may be used in a variety of diagnostic imaging regimes, such as imaging of circulatory systems, genitourinary systems, hepatobiliary systems, central nervous systems, tumors, and abscesses among others.
    • 公开了一种诊断成像方法,其包括向受试者施用药物制剂,所述制剂包含具有结构I的对比增强剂及其盐,其中R1在每次出现时独立地为羟基,C1-C3羟烷基或C1 -C 3烷基,b为0-4; R2-R7各自独立地为氢,C1-C3羟基烷基或C1-C3烷基,条件是R1-R7中的至少一个为羟基或C1-C3羟烷基; 并且其中Q是一个或多个电荷平衡抗衡离子; 和一种或多种药学上可接受的载体和赋形剂。 对受试者进行诸如磁共振成像的诊断成像技术。 该技术可用于各种诊断成像方案,例如循环系统的成像,泌尿生殖系统,肝胆系统,中枢神经系统,肿瘤和脓肿等。